期刊文献+

降压药阿雷地平及其相关杂质的合成与表征

Synthesis and Characterization of Antihypertensive Drug Aranidipine and Its Related Impurities
下载PDF
导出
摘要 建立了降压药阿雷地平新的合成路线,并讨论了新合成方法的优化条件,反应整体收率提高了20%;结合阿雷地平的结构特点和合成工艺分析出6种杂质,并提供了其制备方法和表征结果;采用高效液相色谱(HPLC)法测定阿雷地平中的相关杂质,为其质量标准的制定提供了实验依据. In this paper,a high-yield synthetic scheme of aranidipine was created.The optimization conditions of the new synthetic method were discussed,and the overall yield increased by 20%.Through the structural characteristics and synthetic process,six kinds of Aranidipine impurities were found,whose preparation methods and characterization were provided in the meantime.Moreover,the high performance liquid chromatography(HPLC)method was established for the determination of related impurities in Aranidipine,and was able to supply an experimental basis for the formulation of its quality standard.
作者 李晶 苏伟 王学元 傅鹏 孙艳 LI Jing;SU Wei;WANG Xueyuan;FU Peng;SUN Yan(School of Chemical Engineering,Tianjin University,Tianjin 300072,China;Increase(Tianjin)Innovative Medicine Research Co.,Ltd.,Tianjin 300385,China;Department of Chemistry,School of Science,Tianjin University,Tianjin 300072,China)
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2022年第2期164-171,共8页 Chemical Journal of Chinese Universities
基金 天津市应用基础与前沿技术研究计划(批准号:14JCYBJC21200)资助。
关键词 阿雷地平 杂质 高效液相色谱 Aranidipine Impurity High performance liquid chromatography
  • 相关文献

参考文献7

二级参考文献63

  • 1王华,李长彬,刘劲松.硝苯地平治疗高血压使用情况调查[J].中国实用内科杂志,2013,33(S1):138-139. 被引量:11
  • 2顾复生.硝苯地平控释片的临床应用进展[J].中华心血管病杂志,1994,22(5):327-328. 被引量:33
  • 3张石革,马国辉,臧靖.二氢吡啶类钙通道阻滞剂的研究进展与合理应用[J].中国全科医学,2006,9(4):314-316. 被引量:13
  • 4杨贯羽,宋延林,嵇耀武,黄志新.1,4-二氢吡啶类化合物的合成[J].郑州大学学报(自然科学版),1996,28(2):86-89. 被引量:9
  • 5Ashimori A,Uchida T,Ohtaki Y,et al.Synthesis and pharmacological effects of optically active 2-[4-(4-benzhydryl-1-piperazinyl) phenyl] ethyl methyl 1,4-dihydro-2,6-dimethyl4-(3-nitrophenyl) -3,5-pyridinedicarboxylate hydrochloride[J].Chem Pharm Bull,1991,39(1):108-111.
  • 6Shibanuna T,Iwanani M,Okuda K,et al.Synthesis of optically active 2-(N-benzyl-N-methylamino) ethyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (Nicardipine)[J].Chem Pharm Bull,1980,28(9):2809-2812.
  • 7Adams TC,Rzeszotarski J.Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl) -3,5-pyridinediacarboxylic and their use as calcium antagonists[P].US:5135936,1992-08-04.(CA 1993,118:6867)
  • 8Anonymous. Aranidipine[J]. Drugs Future, 1997, 22 (1): 63-64.
  • 9Ohno S, Komatsu O, Mizukoshi K, et al. Synthesis of asymmetric 4-aryl-1,4-dihydro-2,6-dimethyl- 3,5-pyridinedicarboxylates with vasodilating and antihypertensive activities [J]. Chem Pharm Bull (Tokyo), 1986, 34(4): 1589-1606.
  • 10Ohno S, Mizukoshi K, Komatsu O, et al. 1,4-Dihydropyridine compounds: US, 4446325[P]. 1984-05-01. (CA 1983, 99: 88063)

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部